Pembrolizumab significantly reduced the risk of event free survival events by 30% compared with standard of care.

The Food and Drug Administration (FDA) has approved Zusduri (mitomycin intravesical solution) for adults with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (NMIBC).

Individuals with recall related inquiries can contact Amneal Pharmaceuticals at (833) 582-0812 or via email at [email protected]. Adverse reactions should be reported to ...

Sonu, an AI-enabled wearable device, is now approved for use in pediatric patients aged 12 years and older for the relief of moderate to severe nasal ...

Widaplik is indicated for the treatment of hypertension, including as initial treatment, to lower blood pressure.

The Food and Drug Administration (FDA) has approved Xifyrm ™ (meloxicam injection) for use in adults for the management of moderate to severe pain, alone or in combination with non-NSAID ...

Gilead’s HIV treatment trials involving an investigational integrase strand inhibitor (GS-1720) and an investigational capsid inhibitor (GS-4182) have been put on clinical hold by the Food and Drug ...

HealthDay News — For critically ill adults with sepsis, statin use is associated with reduced mortality, according to a study published online June 5 in Frontiers in Immunology.

A longtime vaccine critic hired by Health Secretary Robert F. Kennedy Jr. is reviewing safety data in an effort to revisit debunked claims that vaccines may cause autism.

In an average-risk colorectal cancer screening population, a blood-based circulating tumor DNA test is feasible.

In real-world cohort, percentage weight reduction at one year was 3.6, 6.8, and 11.9% with early and late discontinuation and nondiscontinuation, respectively.

Recent studies assessed artificial intelligence (AI) assistance tools in their ability to provide quality medical ...